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ABSTRACT 
 
In this study, we investigated γH2AXser139 and 53BP1ser25, DNA damage pathway 
markers, to observe responses to radiation insult.  Two Human Mammary Epithelial Cell 
(HMEC) lines were utilized to research the role of immortalization in DNA damage marker 
expression, HMEC HMT-3522 (S1) with an infinite lifespan, and a subtype of HMEC 184 
(184V) with a finite lifespan.  Cells were irradiated with 50 cGy X-rays, fixed with 4% 
paraformaldehyde after 1 hour repair at 37ºC, and processed through immunofluorescence.  Cells 
were visualized with a fluorescent microscope and images were digitally captured using Image-
Pro Plus software.  The 184V irradiated cells exhibited a more positive punctate response within 
the nucleus for both DNA damage markers compared to the S1 irradiated cells.  We will expand 
the dose and time course in future studies to augment the preliminary data from this research.  It 
is important to understand whether the process of transformation to immortalization 
compromises the DNA damage sensor and repair process proteins of HMECs in order to 
understand what is “normal” and to evaluate the usefulness of cell lines as experimental models. 
INTRODUCTION 
 
DNA damage from ionizing radiation triggers the mobilization of damage sensor proteins 
to damage sites resulting in temporary delay of cell cycle progression and activation of repair 
machinery (1).  ATM (Ataxia Telangiectasia Mutated) and ATR (Ataxia Telangiectasia and Rad-
3-related) proteins are two related kinases central to signaling DNA damage, and recent evidence 
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indicates ATM activation occurs prior to ATR activation following radiation damage (2). The 
published literature of these phenomena has been obtained primarily with human and other 
mammalian fibroblasts.  
A major focus for breast cancer research is to understand the key mechanisms responsible 
for initiating carcinogenesis.  It is the epithelial cell that becomes a cancer cell.  Normal 
epithelial cells have a finite life span and then senesce, and thus are more difficult to study in the 
laboratory.  Evidence exists from studies of human and murine normal mammary glands that 
multiple epithelial cell-subtypes exist with distinct patterns of susceptibility to different subtypes 
of breast cancer (3, 4, 5).  Malignant transformation is a multi-step process in which genetic 
changes in these different cell subtypes can occur due to exposure to a number of environmental 
factors, such as viruses, carcinogens, dietary factors, and radiation.  Mutations of the TP53 gene 
are the most frequent genetic lesion in breast cancer and its loss as a result of mutation is thought 
to be an early step in breast tumorigenesis (6). 
Numerous cell culture models derived from Human Mammary Epithelial Cells (HMEC) 
are available (4, 7, 8).  The role of tumor suppressor proteins, inhibitors of cyclin-dependent 
kinases, telomerase and small G proteins have been defined in normal and various stages in the 
progression to immortalization of HMECs.  In this paper we are investigating whether DNA 
damage foci recruitment after exposure of HMECs to a relatively low dose of X-rays (50 cGy) is 
dependent on immortalization.  We have selected two non-malignant HMECs: the 184V non-
immortalized HMEC with a finite life span, and the immortalized HMEC HMT-3522 (S1) (9, 10, 
11, 12).  Differences in gene expression between these two cell types during normal 
differentiation into polarized acini have recently been compared to test correlation of marker 
genes with poor and good prognosis groups among breast cancer patients (13). 
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We are comparing two markers in the ATM DNA damage pathway for radiation-induced 
effects, histone family 2A member X (γH2AX), and tumor protein TP53 binding protein 1 
(53BP1) (14, 15). Both proteins are phosphorylated in response to DNA damage (16, 17, 18).  
We hypothesize that the transformation process that immortalizes cells for unlimited growth in 
culture may affect the DNA damage response pathway.  Biological cell models cultured in vitro 
in the laboratory are used to investigate many unknown mechanisms of action underlying 
molecular responses to stressors in normal human tissues. It is important to understand biological 
characteristics common to a cell type, as well as differences that may exist in various cell 
models.  
MATERIALS AND METHODS 
 
Cells and Cell Culture Conditions 
 
HMEC HMT-3522 (S1) immortalized cells are non-malignant early passage human cells 
that were made available to our lab by Drs. Mina Bissell and Mary Helen Barcellos-Hoff 
(LBNL).  The cells originated from a reduction mammoplasty of a woman with a non-malignant 
breast lesion and were derived through continuous cell passaging in defined medium (20, 21).  
We used cells from passages #40-60. Cells were grown at 37oC in humidified incubator at 5 % 
CO2  in a chemically-defined medium (DMEM / F12 - H14) composed of DMEM (Dulbecco's 
Modified Eagle's Medium) plus Ham’s F12 (1:1, Invitrogen), 2 mM glutamine, 250 ng/ml 
insulin, 5 mg/ml sheep prolactin, 10 mg/ml transferrin, 1010 M estradiol (all from Sigma, St. 
Louis, MO), 10 ng/ml EGF, 2.6 ng/ml sodium selenite, and 1 µM hydrocortisone (from 
Collaborative Research, MA).  Cells were set up in plastic four well LabTek slides or 60 mm 
plastic Falcon petri dishes at 4 x 104 cells/well or 1x105 respectively five days prior to the 
experiment and were fed every other day. 
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HMEC 184V is a subtype of the 184 HMEC line that is mortal and non-malignant.  These 
cells were kindly provided by Dr. Martha Stampfer (LBNL), who developed this cell line from a 
human non-tumorigenic reduction mammoplasty (10, 19).  Cells were grown as described by 
Stampfer (19) in serum-free MCDB 170+IP Growth Media containing MEBM, (Mammary 
Epithelial Basal Medium, Clonetics Corporation, San Diego, CA) in a 37°C humidified incubator 
at 0.2% CO2.  184V cells were fed every Monday, Wednesday, and Friday, and transferred at 
80% confluency.  Cell transfer consisted of 3X rinses of 0.05% trypsin w/ EDTA 
(Invitrogen/GIBCO) of 3, 2, and 1 ml, respectively, in 100 mm petri dishes.  The 184V cells 
required waiting 30 seconds between trypsin rinses, with the final trypsinization for 5 minutes at 
37°C.  Following the final trypsinization, cells were neutralized (with 10 ml 1X PBS without Ca 
or Mg) and spun down in a centrifuge at 1,000 RPM for 5 minutes.  Cells were resuspended in 
growth media, counted, and plated.  Cells were plated at 2-4 x 104 cells/ml per well into plastic 
four well LabTek slides three days prior to the experiment.  
Irradiation 
 
 Four well LabTek slides and 60 mm petri dishes were irradiated one at a time, on a 
rotating platform, in a 160 kVp Pantak X-ray machine, running at 150 kVp, 20 mA, for a dose of 
radiation of 50 cGy.  Dose calibration was done with a NIST-based calibrated Victoreen probe 
154.  Following irradiation, slides or dishes containing S1 or 184V HMECs were incubated at 
37°C at 5.0% and 0.2% CO2, respectively, until fixation.   
Fixation 
 
Cells were fixed following irradiation, at 1 hour.  Cells were rinsed 2X with PBS and 
then incubated with Nucleoplasmic Extraction Solution (NES): 0.5% Triton-X, 20 mM HEPES 
(pH 7.9), 50 mM NaCl, 3 mM MgCl2, and 200 mM sucrose at RT for 10 minutes.  The cells 
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were rinsed 1X with PBS and fixed with 4% paraformaldehyde for 10 mins at RT in a time 
course after radiation exposure.  Cells were rinsed 2X with PBS, and then PBS was added to 
each area of the slide/dish containing cells, and placed at 4°C overnight.   
Immunofluorescence 
Cells fixed with 4% paraformaldehyde were permeabilized in 0.1% NP-40 in PBS for 30 
minutes.  Cells were blocked with 0.5% casein in PBS for 1 hour, followed by 10% goat serum 
in PBS for 1 hour.  The primary antibodies for γH2AXser139 monoclonal mouse (1:1000 Upstate) 
or 53BP1ser25 polyclonal rabbit (1:200 Bethyl Labs) were applied overnight at 4°C in a 
humidified chamber. 
Cells were rinsed 3X 20 minutes in PBS, and secondary antibody was applied.  Alexa 
488 goat anti-mouse (1:300 Invitrogen) or Alexa 594 goat anti-mouse (1:300 Invitrogen) was 
applied for 1 hour for the S1 or 184V cells, respectively, for γH2AXser139.  Alexa 488 goat anti-
rabbit (1:300 Invitrogen) or Alexa 594 goat anti-rabbit (1:300 Invitrogen) was applied for 1 hour 
for the 184V or S1 cells, respectively, for 53BP1ser25.  Alexa 488 produces a green fluorescent 
signal and Alexa 594 produces a red fluorescent signal. 
Cells were rinsed 3X 15 minutes in PBS, followed by nuclear staining in DAPI (0.25 
µg/ml) for 5 minutes (nucleus stains blue) covered with vectashield, cover-slipped and sealed 
with nail polish. 
Image Acquisition 
A Zeiss Axiovert 200M microscope was used to view fluorescent cell signals which were 
digitally captured with a 40XAPO objective and a QImaging Retiga EX digital CCD camera.  
Image-Pro Plus software was used to acquire individual 40X images. A minimum of five images 
from each experimental condition were taken. 
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Fluorescence Analysis 
 The number of fluorescent cells was manually counted for each image field.   The 
fraction of responders in the field was obtained by dividing the number of positive fluorescent 
nuclei divided by the total number of cells indicated by the blue DAPI stained nuclei.  A 
minimum of 5 images from each sample were analyzed and the data is summarized in Table 1. 
RESULTS 
 A representative fluorescent image from the 5 fields acquired from each 50 cGy 
irradiated sample after 1 hour of incubation at 37°C, and its respective control for each of the two 
DNA damage marker proteins with each cell type is depicted in Figure 1A for the γH2AXser139 
response, and in Figure 2A for the 53BP1ser25 response. A histogram representing the quantitative 
analysis of the fraction of the fluorescence positive cells for the γH2AXser139 response is 
presented in Figure 1B and for the 53BP1ser25 in Figure 2B.  About 20% of the unirradiated 
control samples for the exponentially-growing S1 cells or 184V cells were measured to be 
γH2AXser139 positive.  Although a comparable number of background positive cells were seen for 
each of the cell types, the nature of the fluorescence was quite different.  Most of the signals 
from the S1 control samples were punctuate in nature while some 184V cells showed a 
distribution of both overall nuclear staining as well as punctuate signals.  Both cell lines showed 
increased fluorescent signals one hour after an X-ray dose of 50 cGy, but the fluorescent signals 
had a different appearance.  Most of the positive S1 cells showed global nuclear staining while 
signals from the 184V cells appeared to contain a distribution of both punctuate and overall 
nuclear staining.  Quantitative comparison of the number of positive cells in the DAPI merged 
H2AX images showed that 91.6 ± 9.7% of the 184V cell nuclei were positive compared to the 
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83.4 ± 15.8% positive S1 cells.  This is illustrated in the histograms in Figure 1B.  Error bars 
show the standard deviation between image fields for the same probe and treatment condition.  
 In Figure 2A, the unirradiated S1 cells showed a very small background signal for 
53BP1ser25 fluorescence.  In stark contrast, the 184V cells showed a high background signal of 
small punctate dots.  Both cell types showed increased 53BP1ser25 fluorescence 1 hour after 
exposure to 50 cGy.  Quantitation of the fluorescence signal indicated that 97.8 ± 2.7% of the 
184V cells were fluorescence positive, but only 69.2 ± 12.5% of the S1 cells were positive. 
Results from a student t-test show that the radiation-induced increase in fluorescence in the 184V 
cells are significantly different (p<0.01) than the S1 cells. 
DISCUSSION AND CONCLUSIONS 
 The major observation from the work presented here is that the control background 
fluorescent signals for the two molecular markers used as indicators for radiation damage are 
different for the two non-malignant HMECs studied. Furthermore, although it appears that 
radiation exposure produced a similar level of enhanced γH2AXser139 fluorescent signals in both 
cell lines, we observed significant differences in both the level and in the pattern of radiation-
induced 53BP1ser25 fluorescence signal. The non-immortalized 184V HMECs showed almost 
100% response 1 hour after exposure to 50 cGy with each of the two probes, γH2AXser139 and 
53BP1ser25.  The immortalized HMT-3522 S1 HMECs showed only approximately 70% 53BP1 
response 1 hour after exposure to 50 cGy. To our knowledge, this work represents the first 
documentation of differences in DNA repair markers between two non-malignant HMECs.   
 Both cell types were exponentially dividing cultures at the time of radiation exposure.  
One explanation for the observed differences could be due to variable distributions of cells in the 
cell cycle for each cell type.  However, the magnitude of this difference seems unlikely to 
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account for this possibility, but this needs to be ruled out in future studies by examining the cell 
cycle distribution.  The data presented are for a single radiation dose and time point after 
exposure.  It is therefore possible that the time course of the expression of these DNA damage 
markers is different for each of these cell lines.  This would be an interesting observation and 
future work with a more complete dose response and time course is planned.  It is known that 
multiple genetic changes are required for efficient immortalization of different subtypes of 
normal human mammary epithelial cells leading to carcinogenesis (4) and that some of these 
genetic changes can alter the radiation resistance of carcinoma of the breast (22).  There are 
indications that DNA damage markers like γH2AXser139 can be used as therapeutic targets for 
improving the efficacy of radiation therapy for breast cancer (23) by blocking γH2AX foci 
formation or by inhibiting DNA damage repair processes in breast tumor cells.  It is important to 
understand whether the process of transformation to immortalization compromises the DNA 
damage sensor and repair process proteins of HMECs in order to understand what is “normal” 
and to evaluate the usefulness of cell lines as experimental models. 
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TABLE 
 
Cells Counted 
Control 1 hr post 50 cGy X-ray 
 
 
 
HMEC 
Line 
 
Antibody 
+ Total % + Total % 
γH2AXser139 56 257 22.0 ± 8.1% 405 490 83.4 ± 15.8% 
S1 
53BP1ser25 2  323   0.7 ± 0.1% 353 524 69.2 ± 12.5% 
γH2AXser139 78 329 24.1 ± 7.2% 336 368 91.6 ± 9.7% 
184V 
53BP1ser25 230 298 77.9 ± 15.8% 359 368 97.8 ± 2.7% 
 
Table 1.  Data and calculated percentages for cells counted 
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FIGURE CAPTIONS 
 
Figure 1A.  γH2AXser139 response in control (a, b, e, f) and 50 cGy (c, d, g, h) images for HMEC 
S1 (a-d) and HMEC 184V (e-h). Panels a, c, e, g consist solely of the red signal from 
γH2AXser139 and panels b, d, f, h are color composite images derived from merging the blue 
DAPI nuclear and the red γH2AXser139 images.  
 
Figure 1B. Comparison of the level of positive γH2AXser139  in control or irradiated cell 
populations, in HMECs S1 or 184V.  
 
Figure 2A.  53BP1ser25 response in control (a, b, e, f) and 50 cGy (c, d, g, h) images for HMEC 
S1 (a-d) and HMEC 184V.  Panels a, c, e, g consist solely of the green signal from 53BP1ser25 
and panels b, d, f, h are color composite images derived from merging the blue DAPI nuclear and 
the green 53BP1ser25 images.  
 
Figure 2B. Comparison of the level of positive 53BP1ser25  in control or irradiated cell 
populations of HMECs S1 or 184V.  
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Figure 2A.   
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